about
Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis CEffect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*-corrected, spectrum-modeled MRI.In vivo breath-hold (1) H MRS simultaneous estimation of liver proton density fat fraction, and T1 and T2 of water and fat, with a multi-TR, multi-TE sequence.A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection.Multisite, multivendor validation of the accuracy and reproducibility of proton-density fat-fraction quantification at 1.5T and 3T using a fat-water phantom.Ultrashort echo time spectroscopic imaging (UTESI) of cortical bone.Relaxation effects in the quantification of fat using gradient echo imaging.Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis.Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification.Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 TCombination of complex-based and magnitude-based multiecho water-fat separation for accurate quantification of fat-fraction.Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency.Cross-sectional and longitudinal evaluation of liver volume and total liver fat burden in adults with nonalcoholic steatohepatitisAccuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver diseaseMitochondrial dysfunction in Gulf War illness revealed by 31Phosphorus Magnetic Resonance Spectroscopy: a case-control study.Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels.ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy.In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications.Accuracy of multiecho magnitude-based MRI (M-MRI) for estimation of hepatic proton density fat fraction (PDFF) in children.Feasibility of and agreement between MR imaging and spectroscopic estimation of hepatic proton density fat fraction in children with known or suspected nonalcoholic fatty liver disease.Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease.Reproducibility of MR-based liver fat quantification across field strength: Same-day comparison between 1.5T and 3T in obese subjects.Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trialsIntra- and inter-examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adultsNonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosisBrief report: approaches to 31P-MRS in awake, non-sedated children with and without autism spectrum disorder.Assessing bioenergetic compromise in autism spectrum disorder with 31P magnetic resonance spectroscopy: preliminary report.Inter-examination precision of magnitude-based MRI for estimation of segmental hepatic proton density fat fraction in obese subjects.A quantitative approach to sequence and image weighting.MRI proton density fat fraction is robust across the biologically plausible range of triglyceride spectra in adults with nonalcoholic steatohepatitis.Optimization of region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification.Magnetic Resonance Elastography Measured Shear Stiffness as a Biomarker of Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease.Accuracy of PDFF estimation by magnitude-based and complex-based MRI in children with MR spectroscopy as a reference.Bone marrow fat content is correlated with hepatic fat content in paediatric non-alcoholic fatty liver disease.Cross-sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosis.Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis.Robustness of fat quantification using chemical shift imaging.Assessment of treatment response in non-alcoholic steatohepatitis using advanced magnetic resonance imaging.Effect of intravenous gadoxetate disodium and flip angle on hepatic proton density fat fraction estimation with six-echo, gradient-recalled-echo, magnitude-based MR imaging at 3T.
P50
Q30499178-6E7EA3BC-07B1-449E-AAC3-98CF103B36DEQ30618074-C177D9D5-0A20-493C-87D9-4068476E79EBQ30976946-341A4A48-3052-46EE-811C-BF6DCDC0E827Q31013545-DC3EB2D0-DB1E-48F5-9EC2-E63B1CDFBDB8Q31077527-B49D982E-8355-46DD-A230-87E82B9FA2A8Q31134693-A1256D5C-9B58-4136-B073-3CDD8F64E9BAQ31140579-C9076594-BE5C-485C-A91B-4FE53BAEAEF5Q33402851-EEFD5F7F-620D-48A1-9463-856983187AE7Q33409801-2B35B139-13AB-45EC-A5C7-CC8684A137F6Q33474978-88374262-5B7D-4D56-9E9C-49DCDE56942DQ33787851-FEA44F3D-4773-42B4-A78F-EC736A52C1C7Q33939919-22A232F9-C2BC-4810-BD84-2462777480E4Q34373792-C467481E-4F77-49E0-BEC5-E645C7CA8C71Q34945781-1E04519A-39FF-4AB6-A4D5-3E88E0BEE753Q35039525-395D0E4D-32DA-49CF-8EF1-5D35797ECE18Q35133389-5DFAA86B-EC7A-4D0D-8FDA-268D57DC833DQ35596429-9A05C91B-64BE-4047-8AA0-E73C052F266EQ35597455-EF81F808-3051-4F69-9915-97DDE204F49EQ36075759-C4F93535-F123-4175-96AA-E25C8382A5C1Q36118818-1618DC39-7EC6-4732-B7E6-F2642213F663Q36240453-95FF46F3-B04A-4940-BD21-D22C645A50B7Q36348762-0ABF9299-69FF-49C5-AD86-86021156E45BQ36716748-5E3FC0D1-CA71-443C-A116-47D606F62B0CQ36762917-A1092042-F58D-4BF8-8E85-F12C77F67515Q36762955-A84FFDF2-A8CD-4F91-944C-780BAD25C997Q36785616-3C02BDD8-3F66-4CE8-9E4B-3C7CAD51E220Q36889230-FB144DCD-682C-4E07-A483-51E2D9912C5BQ37597354-65D08A9A-B491-4B57-8070-A67B87B1B2FDQ37698995-DC790EA0-26A5-4FFB-9CF3-6C2FE9845D9CQ37760390-13A3604F-E022-4B00-BA90-F0A30AFA032FQ38603528-58DC2394-6FD1-47FD-8DB5-F83E3F49930DQ38607460-F82BE2D4-B83C-4EEE-A25C-6E259A6EF15DQ38792324-35509CE0-3D6A-4BA2-8080-86FBFF058041Q38890679-08A911A5-AE2A-4E65-A4A0-66EFA304479EQ39034365-D5C03279-9684-4413-A588-4FD45F1DB663Q39329705-53E73DA1-E0A3-4436-9A19-6E915134FA62Q40047726-7BC62352-0734-4E41-BF03-69267A3EE5B5Q40282497-51DA45D3-8394-4641-8E85-2BE33AE881D2Q40367115-505E52A0-826E-4C00-83BC-79FB121CD07EQ40405348-C9AC6A34-9E51-4A34-B57F-F9C67A8C91F1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gavin Hamilton
@ast
Gavin Hamilton
@en
Gavin Hamilton
@es
Gavin Hamilton
@nl
type
label
Gavin Hamilton
@ast
Gavin Hamilton
@en
Gavin Hamilton
@es
Gavin Hamilton
@nl
prefLabel
Gavin Hamilton
@ast
Gavin Hamilton
@en
Gavin Hamilton
@es
Gavin Hamilton
@nl
P106
P31
P496
0000-0001-9302-5546